Search

everythinglearnresearchcommunity

for

Search:↓

SLHA can be hard to diagnose and needs teamwork between specialists.

Hair follicles produce IL-7, which is essential for certain skin lymphoma cells to survive.

Mogamulizumab can cause hair loss and skin rashes.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Hair follicle hyperplasia is common in both benign and malignant skin lymphoproliferative disorders, with a proposed new term "pseudolymphomatous adnexitis."

Fox Fordyce disease can occur in prepubertal girls and may be underdiagnosed.

Patients with mycosis fungoides have a higher risk of heart disease.

Interferon, especially alfa interferon, is an effective treatment for cutaneous T-cell lymphoma with manageable side effects.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Folliculotropic mycosis fungoides has a worse prognosis than other types, with survival rates varying significantly based on subtype and organ involvement.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

Targeted cancer therapies often cause serious skin problems that need careful management.

Chemotherapy can cause skin problems like hair loss, mouth sores, and skin darkening, and recognizing these can affect treatment decisions.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

HIV can cause various severe or unusual skin conditions that help indicate the presence and stage of the disease.

Some patients with mycosis fungoides or Sézary syndrome experience hair loss, which may be similar to alopecia areata or linked to skin lesions, possibly due to abnormal T cells, and bexarotene can help treat it.

A woman with lupus experienced skin death due to a blood clotting disorder after stopping a blood thinner, which healed with treatment.

Laser Doppler velocimetry is a valuable noninvasive tool for skin blood flow research in dermatology.

UVA1-light therapy successfully treated a child's skin condition, mycosis fungoides.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Breast cancer skin metastases are rare, look different, and can be confused with other skin issues, so a biopsy is needed for accurate diagnosis.

Skin and hair changes in horses can indicate serious diseases, and recognizing these signs is important for treatment and management.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Mood stabilizers can cause serious skin reactions; careful monitoring and immediate treatment are crucial.

Some skin lymphomas can look like common skin issues and need careful testing to diagnose correctly.

Psychotropic medications can cause skin problems, including serious conditions, and patients should be monitored closely.